Modulation of the insulin cascade at the proximal level involving the insulin receptor and IRS1/2 has gained considerable interest for explaining the pathophysiology of lipid-induced insulin resistance [15], pinpointing these mechanisms as key drivers of metabolic dysfunction in obesity and T2DM [16]. The gene discussed is IRS1; the disease is Insulin resistance.